- Filed
- Sep 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Sep 14, 2021 | 199.63M sh |
| Shares Diluted | Q1 2022 · Jul 31, 2021 | 199.63M sh |
| Shares Diluted | Q1 2022 · Jul 31, 2020 | 199.63M sh |
| Cash And Equivalents | Q1 2022 · Jul 31, 2021 | $670.43K |
| Cash And Equivalents | Q1 2022 · Apr 30, 2021 | $1.57M |
| Cash And Equivalents | Q1 2022 · Jul 31, 2020 | $875.63K |
| Cash And Equivalents | Q1 2022 · Apr 30, 2020 | $1.14M |
| Stockholders Equity | Q1 2022 · Jul 31, 2021 | $9.31M |
| Stockholders Equity | Q1 2022 · Apr 30, 2021 | $9.77M |
| Current Liabilities | Q1 2022 · Jul 31, 2021 | $26.81M |
| Current Liabilities | Q1 2022 · Apr 30, 2021 | $23.94M |
| Total Liabilities | Q1 2022 · Jul 31, 2021 | $26.81M |
| Total Liabilities | Q1 2022 · Apr 30, 2021 | $23.94M |
| Current Assets | Q1 2022 · Jul 31, 2021 | $23.7M |
| Current Assets | Q1 2022 · Apr 30, 2021 | $22.85M |
| Total Assets | Q1 2022 · Jul 31, 2021 | $34.2M |
| Total Assets | Q1 2022 · Apr 30, 2021 | $32.07M |
| Capex | Q1 2022 · Jul 31, 2020 | $137.78K |
| Sga Expense | Q1 2022 · Jul 31, 2020 | $473.18K |
| Rd Expense | Q1 2022 · Jul 31, 2020 | $361.44K |
| Net Income restated | Q1 2022 · Jul 31, 2020 | −$662.6K |
| Operating Income | Q1 2022 · Jul 31, 2020 | −$978.35K |
| Gross Profit | Q1 2022 · Jul 31, 2020 | $167.18K |
| Revenue | Q1 2022 · Jul 31, 2020 | $7.04M |